ScreenPoint Medical Raises $28 Million

Facebook X LinkedIn Email
ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised $28 million in Series C funding. The funding will accelerate commercial growth of the company’s Transpara AI breast care software, which uses machine learning technology and curated databases of screening mammograms to improve early diagnosis of breast cancer. The investment will also enable further R&D and expansion of the product portfolio. 

ScreenPoint was founded in 2014 as a spinoff from Radboud University Medical Center in Nijmegen, Netherlands. 

Published: August 2021
artificial intelligence
The ability of a machine to perform certain complex functions normally associated with human intelligence, such as judgment, pattern recognition, understanding, learning, planning and problem solving.
Businessfunding roundseries CSeries C fundingScreenPoint MedicalSoftwareartificial intelligencemachine learningAIfundraisingimage recognitioncomputer visionEuropebreast cancermedical

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.